Yi Larson serves as Executive at Turning Point Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Yi Larson has executed 14 insider transactions totaling $3.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 29, 2023 involved receiving (via award) 325,901 shares valued at $0.
Yi Larson currently holds 325,901 shares of Turning Point Therapeutics, Inc. (TPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yi Larson has been a net seller of TPTX stock. They have purchased $100.0K and sold $3.8M worth of shares.
Yi Larson's most recent insider trade was on Mar 29, 2023, when they sold 325,901 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 2, 2021 | TPTX | $51.4K | Sale | 400 | $128.41 | Discretionary |
| Feb 2, 2021 | TPTX | $127.6K | Sale | 1,000 | $127.58 | Discretionary |
| Feb 2, 2021 | TPTX | $772.5K | Option Exercise | 14,298 | $54.03 | Discretionary |
| Feb 2, 2021 | TPTX | $139.2K | Sale | 1,057 | $131.73 | Discretionary |
| Feb 2, 2021 | TPTX | $948.9K | Sale | 7,267 | $130.58 | Discretionary |
| Feb 2, 2021 | TPTX | $593.7K | Sale | 4,574 | $129.80 | Discretionary |
| Feb 1, 2021 | TPTX | $25.2K | Sale | 200 | $126.07 | Discretionary |
| Feb 1, 2021 | TPTX | $267.0K | Sale | 2,143 | $124.60 | Discretionary |
| Feb 1, 2021 | TPTX | $1.1M | Sale | 8,576 | $123.70 | Discretionary |
| Feb 1, 2021 | TPTX | $588.0K | Sale | 4,783 | $122.94 | Discretionary |
| Feb 1, 2021 | TPTX | $848.4K | Option Exercise | 15,702 | $54.03 | Discretionary |
| Sep 10, 2019 | TPTX | $100.0K | Purchase | 2,222 | $45.00 | Discretionary |